...
首页> 外文期刊>NeuroImage: Clinical >Disrupted cerebral metabolite levels and lower nadir CD4+ counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatmentpatients on stable treatment
【24h】

Disrupted cerebral metabolite levels and lower nadir CD4+ counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatmentpatients on stable treatment

机译:稳定治疗的210名接受HIV感染的患者在稳定治疗下的大脑代谢产物水平紊乱和最低的最低CD4 +计数与脑容量不足有关

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cognitive impairment and brain injury are common in people with HIV/AIDS, even when viral replication is effectively suppressed with combined antiretroviral therapies (cART). Metabolic and structural abnormalities may promote cognitive decline, but we know little about how these measures relate in people on stable cART. Here we used tensor-based morphometry (TBM) to reveal the 3D profile of regional brain volume variations in 210 HIV+ patients scanned with whole-brain MRI at 1.5T (mean age: 48.6±8.4years; all receiving cART). We identified brain regions where the degree of atrophy was related to HIV clinical measures and cerebral metabolite levels assessed with magnetic resonance spectroscopy (MRS). Regional brain volume reduction was linked to lower nadir CD4+ count, with a 1–2% white matter volume reduction for each 25-point reduction in nadir CD4+. Even so, brain volume measured by TBM showed no detectable association with current CD4+ count, AIDS Dementia Complex (ADC) stage, HIV RNA load in plasma or cerebrospinal fluid (CSF), duration of HIV infection, antiretroviral CNS penetration-effectiveness (CPE) scores, or years on cART, after controlling for demographic factors, and for multiple comparisons. Elevated glutamate and glutamine (Glx) and lower N -acetylaspartate (NAA) in the frontal white matter, basal ganglia, and mid frontal cortex — were associated with lower white matter, putamen and thalamus volumes, and ventricular and CSF space expansion. Reductions in brain volumes in the setting of chronic and stable disease are strongly linked to a history of immunosuppression, suggesting that delays in initiating cART may result in imminent and irreversible brain damage. Highlights ? We mapped the 3D pattern of brain abnormalities in 210 HIV patients on stable cART. ? Brain atrophy was linked to MRS metabolite disturbances reflecting neuronal injury. ? Lower nadir CD4+ count was associated with greater white matter atrophy.
机译:即使使用联合抗逆转录病毒疗法(cART)可以有效抑制病毒复制,HIV / AIDS病人的认知障碍和脑损伤也很常见。代谢和结构异常可能会促进认知能力下降,但是我们对这些方法与稳定cART患者的关系知之甚少。在这里,我们使用基于张量的形态计量学(TBM)揭示了210名接受1.5T(平均年龄:48.6±8.4岁;均接受cART)的全脑MRI扫描的HIV +患者的210例HIV +患者的区域脑容量变化的3D轮廓。我们确定了脑区域,其中萎缩程度与HIV临床测量和磁共振波谱(MRS)评估的脑代谢物水平有关。区域脑容量减少与最低点CD4 +计数降低相关,最低点CD4 +每减少25点,白质物质体积减少1-2%。即便如此,TBM测量的脑容量仍显示与当前CD4 +计数,艾滋病痴呆综合症(ADC)阶段,血浆或脑脊液(CSF)中的HIV RNA载量,HIV感染的持续时间,抗逆转录病毒CNS渗透效力(CPE)没有可检测的关联。在控制人口统计学因素和进行多次比较后得出的分数或cART年数。额叶白质,基底神经节和额叶中层皮层中的谷氨酸和谷氨酰胺(Glx)升高,以及较低的N-乙酰天门冬氨酸(NAA)升高,与较低的白质,壳聚糖和丘脑体积以及心室和CSF空间扩张有关。在慢性和稳定疾病中,脑容量的减少与免疫抑制的历史密切相关,这表明启动cART的延迟可能会导致即将发生的和不可逆转的脑损伤。强调 ?我们在稳定的cART上绘制了210名HIV病人脑部异常的3D模式。 ?脑萎缩与反映神经元损伤的MRS代谢紊乱有关。 ?最低的最低CD4 +计数与更大的白质萎缩有关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号